— Know what they know.
Not Investment Advice

PETQ NASDAQ

PetIQ, Inc.
1W: +0.2% 1M: +0.8% 3M: +43.4% 1Y: +65.0% 3Y: +25.9% 5Y: +21.2%
$30.98
Last traded 2024-10-25 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $919.2M mcap · 24M float · 3.87% daily turnover

Balance Sheet Trends

Total Assets
$868M +6.0% ▲
5Y CAGR: +11.9%
Total Liabilities
$645M +6.3% ▲
5Y CAGR: +29.9%
Shareholders Equity
$221M +5.4% ▲
5Y CAGR: -2.9%
Cash & Investments
$116M +14.9% ▲
5Y CAGR: +11.9%
Total Debt
$476M -0.8% ▼
5Y CAGR: +33.6%
Net Debt
$360M -5.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021FY2022FY2023
— Assets —
Cash$27M$33M$79M$101M$116M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$27M$33M$79M$101M$116M
Net Receivables$71M$103M$114M$118M$143M
Inventory$80M$98M$96M$143M$159M
Other Current Assets$7M$8M$9M$8M$13M
Total Current Assets$185M$242M$299M$370M$431M
Property, Plant & Equip.$73M$83M$97M$92M$76M
Goodwill & Intangibles$351M$444M$422M$356M$359M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$3M$2M$2M$1M$2M
Total Non-Current Assets$487M$529M$521M$449M$437M
Total Assets$673M$772M$820M$819M$868M
— Liabilities —
Accounts Payable$52M$68M$55M$113M$139M
Short-Term Debt$4M$13K$8M$15K$16M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$9M$18M$15M$20M$10M
Total Current Liabilities$73M$101M$98M$149M$190M
Long-Term Debt$251M$404M$448M$443M$438M
Other Non-Current Liab.$117K$1M$459K$1M$4M
Total Non-Current Liabilities$271M$376M$466M$458M$456M
Total Liabilities$344M$478M$564M$607M$645M
— Equity —
Common Stock$28K$29K$29K$29K$29K
Retained Earnings-$16M-$93M-$115M-$163M-$161M
Accumulated OCI-$1M-$686K-$684K-$2M-$2M
Total Stockholders Equity$283M$262M$253M$210M$221M
Total Liabilities & Equity$673M$772M$820M$819M$868M
— Key Metrics —
Total Debt$280M$388M$481M$463M$476M
Net Debt$252M$354M$401M$362M$360M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms